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The ability of Legionella pneumophila to cause pneumonia
is determined by its capability to evade the immune system
and grow within human monocytes and their derived macro-
phages. Human monocytes efficiently activate caspase-1 in
response to Salmonella but not to L. pneumophila. The molec-
ular mechanism for the lack of inflammasome activation dur-
ing L. pneumophila infection is unknown. Evaluation of the
expression of several inflammasome components in human
monocytes during L. pneumophila infection revealed that the
expression of the apoptosis-associated speck-like protein
(ASC) and the NOD-like receptor NLRC4 are significantly
down-regulated in human monocytes. Exogenous expression
of ASC maintained the protein level constant during L. pneu-
mophila infection and conveyed caspase-1 activation and re-
stricted the growth of the pathogen. Further depletion of ASC
with siRNA was accompanied with improved NF-B activation
and enhanced L. pneumophila growth. Therefore, our data
demonstrate that L. pneumophilamanipulates ASC levels to
evade inflammasome activation and grow in human mono-
cytes. By targeting ASC, L. pneumophilamodulates the inflam-
masome, the apoptosome, and NF-B pathway
simultaneously.
Legionella pneumophila is an intracellular bacterium and
the causative agent of Legionnaire pneumonia, which is a se-
vere form of pneumonia that affects the immune-compro-
mised and the elderly (1–4). The ability of L. pneumophila to
cause pneumonia in humans is dependent on its ability to
evade the immune system and multiply within human mono-
cytes and derived macrophages (5–9). In murine macro-
phages, L. pneumophila activates the Nlrc4 inflammasome
leading to the production of active caspase-1 (10–15). Then
Naip5 cooperates with Nlrc4 to mediate caspase-7 activation
downstream of caspase-1, which restricts the intracellular
survival of the organism (16–19). For reasons that are still not
understood, human monocytes and their derived macro-
phages do not activate caspase-1 in response to L. pneumo-
phila and permit intracellular replication of the pathogen
(17).
The apoptosis-associated speck-like protein containing a
caspase recruitment domain (ASC)4 is an adaptor molecule
that mediates inflammatory and apoptotic signals and is pre-
dominantly expressed in monocytes and mucosal epithelial
cells (20). ASC is an integral component of the inflamma-
some, which is a large protein complex responsible for
caspase-1 activation (21–23). Within the inflammasome, ASC
links caspase-1 and NOD-like receptors (NLR) leading to the
activation of caspase-1 (16–19). Many Gram-negative bacte-
ria, such as Salmonella typhimurium, Pseudomonas aerogi-
nosa, Shigella flexneri, and L. pneumophila, are recognized in
murine macrophages by the NLR Ipaf/Nlrc4 leading to
caspase-1 activation through the inflammasome (24, 25).
ASC has been reported to cooperate with NLRP3
(cryopyrin) and NLRP12 (PYPAF7) in inducing NF-B activ-
ity in an overexpression system (26, 27). However, other re-
ports show that ASC uses its caspase recruitment domain for
interaction to down-regulate NF-B signaling (20, 28). There-
fore, ASC can be an inducer or an inhibitor of NF-B depend-
ing on expression level, cell type, and location within the cell
(29).
ASC has also been suggested to induce apoptosis by re-
cruiting caspase-8 and/or Bax (30). Thus, ASC can regulate
the inflammasome and other signaling pathways depending
on the stoichiometry of its expression and on whether other
pyrin domain family proteins are expressed upon activation
(26, 31). Moreover, emerging reports show novel roles for
ASC in disease conditions such as arthritis (32).
Here we demonstrate that L. pneumophila down-regulates
human ASC in primary human monocytes. Remarkably, exog-
enous expression of ASC in primary human monocytes pro-
moted caspase-1 activation in response to L. pneumophila
and hindered bacterial intracellular growth. Moreover, our
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data revealed that ASC controls L. pneumophila infection in
human cells by modulating host cell survival through limiting
NF-B activation leading to early host cell death. Taken to-
gether, our data demonstrate that ASC is a central molecule
that modulates the fate of L. pneumophila within human
monocytes by different mechanisms. Therefore, designated
down-regulation of ASC by L. pneumophila established the
necessary environment for its replication within human
monocytes.
MATERIALS ANDMETHODS
Quantitative PCR—Total RNA was extracted from primary
human monocytes and lysed in TRIzol (Invitrogen), and 1–2
g of the RNA was converted to cDNA by ThermoScript
RNase H reverse transcriptase (Invitrogen). 20–60 ng of the
converted cDNA was used for quantitative PCR with SYBR
Green I PCR master mix in the StepOne Plus real time PCR
system (Applied Biosystems). The target gene Ct values were
normalized to the Ct values of two housekeeping genes (hu-
man GAPDH and CAP-1, accordingly to the cell origin) and
expressed as relative copy number, as described previously
(33). Primers used in the study are presented in supplemental
Table 1.
Bacterial Strains—L. pneumophila strain Lp02 is a thymine
auxotrophic derivative of Philadelphia-1 (3). L. pneumophila
was cultured as described previously (17). All experiments
were performed at a low multiplicity of infection of 0.5 or 1,
followed by centrifugation and rinsing of the wells after 30
min except when otherwise indicated (34). All experiments
were performed in the absence of ferric nitrate and L-cysteine
from the monocytes or macrophage culture medium to allow
L. pneumophilamultiplication only intracellularly. Viable
bacteria per 5 105 cells per well were quantified as de-
scribed previously (8). The quantification of the colony-form-
ing units (CFU) in vitro was performed more than four inde-
pendent times as described previously (8).
Primary Human Monocytes—Human buffy coats were ob-
tained from the local Red Cross, and monocytes were isolated
by CD14-positive selection as described previously (35).
Generation of THP1 Cell Line Stably Expressing YFP-ASC—
To make a fusion protein, ASC was amplified from cDNA by
PCR and inserted at the C terminus of yellow fluorescent pro-
tein (YFP) on the basis of pLenti6/V5 plasmid (Invitrogen), as
described previously (36). After plasmid verification by se-
quencing, we generated lentivirus and transduced THP-1 cells
(ATCC, lot 385653) with 10–15% efficiency, as described in
detail previously (36). Stably transduced cells were selected
with blasticidin (Invitrogen) for 10 days followed by two
rounds of flow sorting using FACS ARIA (BD Biosciences),
resulting in nearly 100% yield of stably transduced THP-1
cells.
Intracellular Growth of L. pneumophila—Monocytes were
infected as described previously (8). At the designated time
points, monocytes were lysed and plated for colony-forming
units (CFUs).
Immunoblotting—Cell lysates or supernatants were pre-
pared and immunoblotted with an antibody that recognizes
phospho-p65, phospho-IKK, and IKK (Cell Signaling),
actin (Abcam), NLRC4 and ASC (Alexis Biochemicals), and
human caspase-1 and pro-IL-1 (Dr. Mark Wewers). The
blots were then treated with appropriate secondary antibody
as described previously (8).
Cytotoxicity Assays—In vitro quantification of cytoplasmic
(apoptosis) histone-associated DNA fragments was performed
using the cell death detection ELISAPlus photometric enzyme
immunoassay kit from Roche Applied Science to the specifi-
cations of the manufacturer.
Transfection of Primary Human Monocytes with Small In-
terfering RNA—Small interfering RNA (siControl and siASC)
was purchased from Dharmacon and nucleofected into the
cells with the Lonza apparatus, as described previously (17,
36). A plasmid coding ASC tagged with YFP was nucleofected
into the cells with the Lonza apparatus according to the man-
ufacturer’s protocol.
Statistical Analysis—All experiments were done at least
three independent times and yielded similar results. Compari-
sons of groups for statistical differences were done using Stu-
dent’s two-tailed t test. p value0.05 was considered
significant.
RESULTS
Primary Human Monocytes Do Not Activate Caspase-1 in
Response to L. pneumophila—Because recognition of L. pneu-
mophila by the murine Nlrc4 inflammasome is accompanied
by caspase-1 activation and restriction of infection (8, 13, 17,
37), we examined if L. pneumophila infection activates the
inflammasome in human monocytes. Primary human mono-
cytes were infected with L. pneumophila, and the cleavage of
caspase-1 was examined. Given that cleaved caspase-1 and
IL-1 are released from monocytes once activated, we exam-
ined their amount in culture supernatants. Caspase-1 was not
cleaved in response to L. pneumophila after 8 h of infection
(Fig. 1A). Consequently, IL-1 production was minimal after
a similar incubation time (Fig. 1B). It is possible that L. pneu-
mophila deliberately avoids its own detection by the NLRC4
FIGURE 1.Humanmonocytes do not activate caspase-1 or IL-1 in re-
sponse to L. pneumophila infection. Primary humanmonocytes were in-
fected or not (NT) with L. pneumophila (Leg), L. monocytogenes (Lm) for 8 h,
or S. typhimurium (Sal) for 4 h. A, cell culture supernatants were collected
and analyzed by Western blot with anti-caspase-1 antibody. B, culture su-
pernatants of primary humanmonocytes infected with L. pneumophila or S.
typhimuriumwere analyzed for active IL-1 by ELISA.
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inflammasome by an unknown mechanism. It is also possible
that the NLRC4 inflammasome is poorly functional in pri-
mary human monocytes. To distinguish between these possi-
bilities and because Salmonella is detected by NLRC4, pri-
mary human monocytes were infected with Salmonella, and
the release of active caspase-1 and IL-1 in culture superna-
tants was examined. Within 4 h of Salmonella infection
caspase-1 was efficiently cleaved as observed by the detection
of the p20 in culture supernatants (Fig. 1A). Accordingly, sig-
nificant amounts of IL-1 were detected in culture superna-
tants of primary human monocytes infected with Salmonella
(Fig. 1B). Furthermore, human monocytes were able to detect
Gram-positive organisms such as Listeriamonocytogenes,
which was accompanied by caspase-1 activation (Fig. 1A).
Therefore, the human inflammasome complex in general and
the NLRC4 inflammasome in particular are perfectly func-
tional in primary human monocytes, yet it is not activated in
response to L. pneumophila.
L. pneumophila Reduces ASC and NLRC4 mRNA and Their
Expression in Primary Human Monocytes—To understand
the role of the inflammasome during L. pneumophila infec-
tion of human monocytes, primary human monocytes were
infected with L. pneumophila for 4 and 24 h. Caspase-1, pro-
IL-1, ASC, and NLRC4 expressions were examined at the
mRNA and protein levels using quantitative RT-PCR and
Western blot, respectively (Fig. 2). Our results demonstrate
that the expression of caspase-1 and pro-IL-1 was signifi-
cantly increased at 4 h and then decreased after 24 h of L.
pneumophila infection (Fig. 2, A and B). Western blot analysis
showed that the levels of caspase-1 and IL-1 proteins corre-
lated with mRNA levels revealed by RT-PCR (Fig. 2, A and B,
lower panel).
On the other hand, the NLRC4 message was significantly
suppressed at 4 h and remained low after 24 h of infection by
L. pneumophila (Fig. 2C). Western blot analysis showed that
NLRC4 protein levels decreased after the decrease in mRNA
(Fig. 2C). Next, we explored the expression of PYCARD/ASC
mRNA in primary human monocytes because it is a general
adaptor molecule in the inflammasome. We found that L.
pneumophila infection diminished PYCARD mRNA expres-
sion within 4 h of infection and remained low at 24 h (Fig.
2D). The ASC protein level was decreased within 24 h after
infection in the same samples (Fig. 2D). As an independent
control, mRNA levels of other molecules such as annexin1
and pyrin were not altered during L. pneumophila infection
(supplemental Fig. 1). To further confirm our observation, we
examined the expression of the same inflammasome compo-
nents in the human monocytic cell line THP-1. The supple-
mental Fig. 2 shows that both NLRC4 and ASC were down-
regulated in response to L. pneumophila infection in THP-1
cells that are also permissive to L. pneumophila growth.
Therefore, our results reveal that L. pneumophila infection
decreases the expression of essential inflammasome compo-
nents such as NLRC4 and ASC in permissive primary human
monocytes and in human monocytic cell lines.
Exogenous Expression of ASC in Human Monocytes Restores
Caspase-1 Activation in Response to L. pneumophila—Despite
its up-regulation, caspase-1 was not activated or released in
culture supernatants of L. pneumophila-infected human
monocytes (Fig. 1). Because mRNAs for ASC and NLRC4
were down-regulated in response to L. pneumophila, we pos-
tulated that their down-regulation contributes to the absence
of caspase-1 activation during L. pneumophila infection. To
test this hypothesis, we transfected primary human mono-
cytes with a plasmid coding ASC tagged with YFP (Fig. 3A).
GFP plasmid was used as control. Exogenous expression of
ASC was calibrated so as to maintain moderate ASC levels
during L. pneumophila. After transfection, cells were infected
with L. pneumophila, and the cleavage of caspase-1 was exam-
ined by Western blot. Notably, endogenous ASC was de-
creased during L. pneumophila infection, yet exogenous ASC
FIGURE 2. Effect of L. pneumophila infection on the expression of
caspase-1, IL-1, NLRC4, and ASC in humanmonocytes. Primary human
monocytes were infected or not (NT) with L. pneumophila for 4 and 24 h at a
multiplicity of infection of 1. The expression of caspase-1 (A), IL-1 (B),
NLRC4 (C), and PYCARD/ASC (D), mRNA (upper panels), and protein levels
(lower panels) were assessed using quantitative RT-PCR andWestern blot-
ting, respectively. The results are displayed as the mean of three independ-
ent experiments S.D. (*, p 0.05; **, p 0.01). Actin was used as a load-
ing control in all panels.
FIGURE 3. Exogenous expression of ASC in humanmonocytes restores
caspase-1 activation. A, primary humanmonocytes were nucleofected
with a plasmid coding ASC tagged with YFP (Y-ASC). A plasmid encoding
the green florescent protein (GFP) was used as a control. Twenty four hours
after nucleofection, cells were lysed, and Y-ASC (52 kDa) and normal ASC
(25 kDa) were assessed using Western blotting. B, human monocytes were
nucleofected with a plasmid encoding GFP or Y-ASC and then they were
either left untreated (NT) or infected with L. pneumophila (Leg) for 24 h at a
multiplicity of infection of 1. Supernatant was collected, and cleaved
caspase-1 (p-20) was assessed via immunoblotting.
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levels remained unchanged (supplemental Fig. 3). Active
caspase-1 (p-20) was detected only in the supernatants of hu-
man monocytes expressing Y-ASC infected with L. pneumo-
phila but not in supernatants derived from human monocytes
transfected with the GFP plasmid prior to L. pneumophila
infection (Fig. 3B). This finding supports the idea that the
down-regulation of ASC mRNA by L. pneumophilamay con-
tribute to the lack of caspase-1 activation in human
monocytes.
Exogenous Expression of ASC Restricts L. pneumophila In-
fection and Diminishes NF-B Activation—To further investi-
gate the role of ASC during L. pneumophila infection, both
THP-1 cells stably overexpressing Y-ASC and normal THP-1
cells were infected with L. pneumophila, and the ability of L.
pneumophila to grow intracellularly was then examined by
scoring CFUs within 24 h. THP-1 cells allowed L. pneumo-
phila replication, whereas those expressing Y-ASC did not
(Fig. 4A). To understand the mechanism by which ASC may
regulate L. pneumophila infection, apoptosis was evaluated in
THP-1 cells after 24 h of infection (Fig. 4B). Exogenous ex-
pression of ASC in THP-1 cells increased cell death induced
in response to L. pneumophila infection (Fig. 4B). L. pneumo-
phila activates NF-B to extend host cell survival until it rep-
licates intracellularly. Given that ASC may activate or inhibit
NF-B activation depending on the circumstances, we exam-
ined the effect of ASC on the phosphorylation of IKK and
p65 (Fig. 4C). Exogenous expression of ASC decreased the
phosphorylation of IKK and p65. Therefore, ASC restricts
L. pneumophila growth by hindering NF-B activation.
Down-regulation of ASC in Human Monocytes by siRNA
Allows More L. pneumophila Growth and More NF-B
Activation—ASC expression in human monocytes is de-
creased during L. pneumophila infection and that is accompa-
nied by permissiveness to infection. To further confirm the
contribution of ASC in restriction of L. pneumophila infec-
tion, primary human monocytes were transfected with siRNA
specific for ASC or control siRNA (Fig. 5A). Intracellular
growth of L. pneumophila was evaluated by scoring CFU
within 24 h of infection. Notably, depletion of ASC allowed
more L. pneumophila growth when compared with human
monocytes harboring scrambled siRNA as a control (Fig. 5B).
Therefore, ASC also controls L. pneumophila infection in hu-
man monocytes independently of caspase-1. To discern the
mechanism by which depletion of ASC may allow more L.
pneumophila growth, NF-B activation was examined in hu-
man monocytes harboring siRNA specific for ASC or control
siRNA after L. pneumophila infection for 20, 40, or 60 min.
Our data show that human monocytes treated with siRNA
specific for ASC permitted more phosphorylation of IKK
and p65 than cells treated with control siRNA (Fig. 5C). Thus,
in the context of L. pneumophila infection, ASC hinders
NF-B activation. Taken together, ASC controls L. pneumo-
phila infection in a caspase-1-dependent and -independent
manner.
DISCUSSION
Pathogens have developed different mechanisms to avoid
the engagement of the inflammasome and its activation (38).
Viruses utilize proteins to bind ASC and prevent inflamma-
some assembly or disrupt the proteolytic activity of caspase-1.
Yersinia enterocolitica express proteins that prevent caspase-1
oligomerization. P. aeruginosa andMycobacterium tuberculo-
sis generate molecules that block the activation of the NLRC4
and NLRP3 inflammasomes, respectively (38). In this study,
we demonstrate that L. pneumophila suppresses the expres-
sion of ASC, thus preventing the activation of the NLRC4 in-
FIGURE 4. Exogenous expression of ASC in THP-1 cells restricts L. pneumophila infection, increases apoptosis, and deters NF-B activation. A, THP-1
cells overexpressing Y-ASC and normal THP-1 were infected with L. pneumophila, and bacterial growth was assessed at 1 and 24 h after infection by count-
ing the CFUs. The bacterial count is displayed as log CFU/ml. The results are displayed as the mean of three independent experiments S.D. B, THP-1 cells
overexpressing Y-ASC and normal THP-1 were infected or not (NT) with L. pneumophila (Leg), and apoptosis was evaluated after 24 h of infection. The re-
sults are displayed as the mean of three independent experimentsS.D. (*, p 0.05; **, p 0.01.) C, THP-1 overexpressing Y-ASC and normal THP-1 were
infected or not (0) with L. pneumophila for 20, 40, or 60 min. Levels of phosphorylation of IKK and p65 were detected using immunoblots with corre-
sponding antibodies. Actin was used as loading control.
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flammasome. This finding explains the lack of caspase-1 acti-
vation and IL-1 release during infection of human
monocytes. This also provides mechanistic insight for the
permissiveness of human monocytes to L. pneumophila
infection.
Caspase-1 and IL-1 were up-regulated in human mono-
cytes during L. pneumophila infection, yet they were not acti-
vated or released in culture supernatants of infected mono-
cytes. Caspase-1 activation in response to L. pneumophila was
re-instated when ASC was exogenously expressed under a
different promoter impervious to L. pneumophila. Concur-
rently, the activation of caspase-1 was accompanied with re-
striction of infection. Thus, the down-regulation of ASC dur-
ing L. pneumophila infection dampened caspase-1 activation
and its bactericidal consequences. However, we believe that
the down-regulation of ASC impinges on several pathways
not only on caspase-1 activation.
Because L. pneumophila resides in macrophages for 6–8 h
before replication starts, it must ensure the survival of the
host cell for an extended duration (10, 14, 15). To achieve
this, L. pneumophila activates NF-B in a TLR5-dependent
manner at early stages and in a TLR5-independent manner at
later stages of infection for up to 30 h (10, 15). The mecha-
nism for the prolonged activation of NF-B for several hours
is still not clear. Here we demonstrate that ASC prevents
NF-B activation induced by L. pneumophila, thus its down-
regulation could be an elegant virulence strategy employed by
L. pneumophila to extend host cell survival allowing more
intracellular growth (10, 15).
Optiz and co-workers (39) demonstrated that exogenous
expression of human NLRC4 and human NAIP restricts L.
pneumophila. Yet their study did not offer a mechanism for
restriction and did not examine caspase-1 activation. Anders
and co-workers (40) recently showed that NLRs tend to be
down-regulated in human cells and up-regulated in murine
cells in response to LPS. Thus, it is possible that, similar to
NLR expression patterns, the down-regulation of ASC during
L. pneumophila infection is an inherent response of human
monocytes to infection exploited by the pathogen to avoid
caspase-1 activation and to establish infection. Alternatively,
it is plausible that L. pneumophila intentionally down-regu-
lates ASC in human monocytes to avoid the detrimental
consequences of caspase-1 activation. We favor the second
possibility because Salmonella infection of human mono-
cytes was not accompanied by down-regulation of ASC,
and caspase-1 was efficiently activated (data not shown).
This prospect is supported by a study in clinically ill pa-
tients showing that the ASC gene expression levels are ele-
vated irrespective of the infectious agent (41). This is also
supported by several studies demonstrating that ASC is
up-regulated in human monocytes and neutrophils during
inflammation (30, 42). Taken together, it is likely that L.
pneumophila uses many of its genes that encode eu-
karyote-like proteins or motifs to modulate human ASC
functions to its advantage (43, 44).
Therefore, by down-regulating ASC, L. pneumophila
achieves several aims; it avoids caspase-1 activation, evades
bacterial clearance, and extends host cell survival. This is
an elegant mechanism by which L. pneumophila exploits
an adaptor molecule to establish infection in human
monocytes.
FIGURE 5.Depletion of ASC in primary humanmonocytes with specific siRNA allowsmore L. pneumophila growth and improves NF-B activation.
A, human monocytes were transfected with ASC-specific or control siRNA and then the expression of ASC was examined by quantitative PCR and by West-
ern blot. B, transfected cells described in Awere infected with L. pneumophila, and bacterial growth was evaluated by scoring CFU. The results are displayed
as log CFU/ml, the mean of three independent experiments S.D. (**, p 0.01). Primary human monocytes transfected with siRNA targeting ASC (siASC) or
control siRNA (siCTR) were infected or not (0) with L. pneumophila for 20, 40, or 60 min. The phosphorylation of IKK and p65 was examined by Western
blots using corresponding antibodies. Actin was used as loading control.
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